Among the companies whose shares are expected to actively trade
in Tuesday's session are Avon Products Inc. (AVP), Michael Kors
Holdings Ltd.'s (KORS) and Hospira Inc. (HSP).
Avon Products' shares shed 4.2% to $16.80 premarket after the
beauty products seller reported fourth-quarter results that missed
expectations, with gross margins declining as a result of commodity
cost pressures and an inventory-related charge in Brazil.
Michael Kors' fiscal third-quarter earnings rose 47% as the
high-end apparel designer's revenue grew more than expected. Shares
were trading 8.6% higher at $36.50 premarket as the company's
profit also beat expectations.
Hospira swung to a fourth-quarter loss despite
better-than-expected sales as charges related to the company's
efforts to resolve quality-related issues at some of its plants
weighed on results. Shares shed 3.6% to $33 premarket.
Insight Enterprises Inc.'s (NSIT) fourth-quarter earnings surged
39% as the informational technology services company reported
sharply higher sales in its Asia Pacific region. Shares were up 12%
at $21.24 premarket as the company easily beat earnings
expectations and forecast upbeat 2012 income.
Perry Ellis International Inc. (PERY) has launched a review of
its brand portfolio, a disclosure the retailer offered projected
disappointing fiscal fourth-quarter results. Shares fell 7.5% to
$15.50 premarket.
Ultra Clean Holdings' (UCTT) fourth-quarter earnings more than
doubled after a tax benefit, though the supplier for original
equipment manufacturers in the semiconductor, flat panel and other
industries saw its revenue hurt by weak demand. Shares jumped 16%
to $9.05 premarket.
Watson Pharmaceuticals Inc.'s (WPI) fourth-quarter earnings rose
as the introduction of a generic version of Pfizer Inc.'s (PFE)
cholesterol drug Lipitor and other products boosted sales. For
2012, the company raised its per-share earnings estimate. Shares
climbed 2.2% to $59 premarket.
Masco Corp.'s (MAS) fourth-quarter loss narrowed as the
building-products maker reported lower impairment charges as well
as an income tax benefit, though the company's sales grew
less-than-expected. Shares fell 4.8% to $12.60 premarket as Masco's
adjusted loss also missed analyst expectations.
Zipcar Inc. (ZIP) swung to a larger-than-expected fourth-quarter
profit as a jump in membership helped the car-sharing company book
its second straight quarter of profitability. Revenue in the first
quarter, which represents its slowest period seasonally, was pegged
in the range of $58 million to $60 million. Wall Street is
currently looking for $60 million. Shares shed 3.4% to $15.60
premarket.
DuPont Co. (DD) and Yingli Green Energy Holding Co. Ltd.'s (YGE)
China subsidiary signed a $100 million deal to help increase the
supply of photovoltaic materials for the adoption of solar energy.
Yingli's American depositary shares declined 2.3% to $5.17, while
Dupont was unchanged at $50.60 premarket.
Rackspace Hosting Inc.'s (RAX) fourth-quarter profit rose 85% as
the company posted improved revenue and a larger customer base.
Shares jumped 9.7% to $53.98 in premarket trading as results beat
analyst expectations.
Health Management Associates Inc.'s (HMA) fourth-quarter
earnings grew a stronger-than-expected 9.5% as the hospital
operator generated more revenue per admission. Shares rose 7.3% to
$7.40 premarket.
Fossil Inc.'s (FOSL) fourth-quarter earnings rose 22% though
sales growth missed the watch and fashion-accessories retailer's
lowered forecast and margins shrank. The company forecast per-share
earnings below what analysts were expecting. Shares fell 6.6% to
$97.60 premarket.
Biopharmaceutical firm Alnylam Pharmaceuticals Inc. (ALNY) said
it would sell 7 million shares. Shares were down 7.2% at $11.50
premarket.
Magic Software Enterprises Ltd. (MGIC), a provider of mobile and
cloud-enabled application and business integration platforms, said
its fourth-quarter revenues increased 22% year-over-year as
operating and net income both jumped more than 40% over the same
period last year.
Watch List:
Calgon Carbon Corp. (CCC), which makes activated carbons and
purification systems, said it expects its fourth-quarter revenue to
miss analyst expectations and said its earnings for the quarter
will be hurt by a slew of charges.
Charles River Laboratories International Inc. (CRL) swung to a
fourth-quarter profit following prior-year write-downs of $395
million mostly related to its preclinical-services business. The
drug-research services provider's latest results exceeded analysts'
expectations.
FIS Inc.'s (FIS) fourth-quarter earnings rose 5.8% as the
financial services company reported improved revenue in all three
major segments, led by international solutions.
The U.S. Food and Drug Administration granted Gilead Sciences
Inc.'s (GILD) antiretroviral drug Truvada a priority-review
schedule, advancing what could become the first treatment labeled
for HIV prevention.
Limelight Networks Inc.'s (LLNW) fourth-quarter loss widened
slightly as the software-services company posted higher expenses,
though revenue rose. The company's adjusted loss was better than
analysts had expected.
Standard & Poor's Ratings Services raised its outlook on
Meritor Inc. (MTOR) to positive from stable, citing expectations of
sales growth in 2012.
Raymond James Financial Inc. (RJF) said it plans to sell 10.5
million shares, including one million shares offered by selling
stockholders, to help fund its acquisition of brokerage Morgan
Keegan & Co.
Western Union Co. (WU) unveiled a proposal to declassify its
board structure and said it won't submit a management proposal for
proxy access at its 2012 annual meeting.
-Edited by Corrie Driebusch and Drew FitzGerald; write to
corrie.driebusch@dowjones.com and
andrew.fitzgerald@dowjones.com